CYduct Diagnostics (CYDX) has a profit margin of -180.14%, below the sector sector average of 13.4%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
CYduct Diagnostics (CYDX) currently reports a profit margin of -180.14% as of September 2026. That compares with -562.03% in the prior-year period — up 67.9% year over year. That is below the sector sector average of 13.4%. Use the charts on this page to explore CYduct Diagnostics's profit margin history and peer comparisons.
CYduct Diagnostics's profit margin increased from -562.03% to -180.14% — a 67.9% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
CYduct Diagnostics's profit margin of -180.14% is lower than the its sector sector average of 13.4%. That is roughly 1444.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but CYduct Diagnostics's current -180.14% should be judged against industry norms (sector average: 13.4%) and against CYDX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -180.14%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.4%. From there, open related valuation or income-statement pages for CYduct Diagnostics, and consider following CYDX for alerts when major investors trade the stock.